Scarica l'app Stockscreener
4.24
1.68%
0.07
Precedente Chiudi:
$4.17
Aprire:
$4.21
Volume 24 ore:
603.23K
Relative Volume:
0.48
Capitalizzazione di mercato:
$542.15M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-47.11
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-5.15%
1M Prestazione:
-25.61%
6M Prestazione:
+1.68%
1 anno Prestazione:
-18.77%
Intervallo 1D:
$4.19
$4.375
Intervallo di 1 settimana:
$4.085
$4.51
Portata 52W:
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.24 | 533.20M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump - simplywall.st
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - marketscreener.com
Cytek Biosciences, Inc. (CTKB): Investor Outlook On A Promising 37.61% Upside Potential - DirectorsTalk Interviews
Is Cytek Biosciences Inc. in a long term uptrendJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - mfd.ru
Cytek Biosciences Stock (CTKB) Opinions on Preliminary Q4 and FY2025 Revenue Results - Quiver Quantitative
Can Cytek Biosciences Inc. stock hit analyst price targets2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
New York State Common Retirement Fund Has $1.15 Million Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Why Cytek Biosciences Inc. stock is trending among retail tradersPortfolio Update Summary & AI Enhanced Market Trend Forecasts - mfd.ru
What You Can Learn From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) P/S - 富途牛牛
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Brown Capital Management LLC Has $17.20 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2%Should You Buy? - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2% – Should You Buy? - Defense World
Market Outlook: Does Cytek Biosciences Inc stock benefit from AI growthEarnings Recap Report & Technical Buy Zone Confirmations - baoquankhu1.vn
This Cytek Biosciences Insider Increased Their Holding By 169% Last Year - Yahoo Finance
Cytek Biosciences Data Breach Investigation - Strauss Borrelli PLLC
Aug Closing: Is Cytek Biosciences Inc stock overvalued or fairly priced2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Cytek Biosciences, Inc. (CTKB) Investor Outlook: Analyzing The 8.70% Potential Upside - DirectorsTalk Interviews
Institutional owners may take dramatic actions as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) recent 6.9% drop adds to one-year losses - simplywall.st
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsJuly 2025 Big Picture & High Conviction Investment Ideas - bollywoodhelpline.com
CYTEK BIOSCIENCES Q4 2025 Earnings Preview: Recent $CTKB Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2%Here's What Happened - MarketBeat
Cytek Biosciences, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of “Hold” from Analysts - Defense World
Cytek Biosciences Preliminary Q4 Revenue Up 8% - Nasdaq
Cytek Biosciences Reports Preliminary Revenue of Approximately $201 Million for Full Year 2025 - Quiver Quantitative
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewswire
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Will Cytek Biosciences Inc. (8EQ) stock top growth indexesWeekly Profit Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Why Cytek Biosciences Inc. stock is a must watch in 20252025 Pullback Review & Community Consensus Trade Signals - Улправда
Is Cytek Biosciences Inc. stock attractive for retirement portfoliosRisk Management & Technical Confirmation Trade Alerts - Улправда
What analyst consensus implies for Cytek Biosciences Inc. (8EQ) stockBond Market & Weekly High Return Forecasts - Улправда
CTKB FinancialsIncome Statement - Quiver Quantitative
Cytek Biosciences (NASDAQ:CTKB) Given New $5.00 Price Target at TD Cowen - MarketBeat
User | bentoncourier.comCytek Biosciences, Inc.Common Stock (Nasdaq:CTKB) Stock Quote - FinancialContent
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt In A Risky Way? - Futubull
2026 world cup standings odds: How currency fluctuations impact Cytek Biosciences Inc. stock2026 world cup usa national team round of 16 playmakers transition play match prediction analysis - Улправда
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCandlestick Pattern Analysis & Affordable Portfolio Strategies - earlytimes.in
What risks investors should watch in Cytek Biosciences Inc stockGap Down & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ
How currency fluctuations impact Cytek Biosciences Inc. stockStock Screening Results & Big Data Market Reports - bollywoodhelpline.com
What dividend safety score for Cytek Biosciences Inc. stockLong-Term Investment Plans & Fast Profit Trading Strategies - bollywoodhelpline.com
Cytek Biosciences webinar explores lung cell communication advances - Traders Union
Cytek Biosciences Data Breach Exposes Social Security Numbers - Claim Depot
Book value per share of Cytek Biosciences, Inc. – DUS:8EQ - TradingView — Track All Markets
How Cytek Biosciences Inc. stock responds to policy changes2025 Trading Volume Trends & Accurate Buy Signal Alerts - Улправда
Pharma News: How Cytek Biosciences Inc. stock responds to policy changesJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Is Cytek Biosciences Inc. (8EQ) stock a buy on weakness2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Is Cytek Biosciences Inc. (8EQ) stock at risk of policy regulationTrade Ideas & High Accuracy Trade Signal Alerts - DonanımHaber
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):